Journal of Vascular Nursing
Volume 25, Issue 3 , Pages 51-54 , September 2007

C-reactive protein measurement in the patient with vascular disease

This article has never been presented other than as a dissertation proposal to a limited audience.

  • Jeanne M. Widener, MSN, RN, CCRN

      Affiliations

    • Corresponding Author InformationReprint requests: Jeanne Widener, MSN, RN, CCRN, 2100 Belltree Drive, Reynoldsburg, OH 43068.

References 

  1. Cimminiello C. PAD (Epidemiology and pathophysiology). Thromb Res. 2002;106:V295–V301
  2. Collins T, Beyth R. Process of care and outcomes in peripheral arterial disease. Am J Med Sci. 2003;325:125–134
  3. Hirsch A, Gloviczki P, Drooz A, et al. Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. J Vasc Surg. 2004;39:474–481
  4. Greaves DR, Channon KM. Inflammation and immune responses in atherosclerosis. Trends Immunol. 2002;23:535–541
  5. Weinhold B, Rüther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J. 1997;327:425–429
  6. Albert M, Glynn R, Ridker P. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation. 2003;108:161–165
  7. Biasucci L, Liuzzo G, Grillo R, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855–860
  8. Chew D, Bhatt D, Robbins M, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation. 2001;104:992–997
  9. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992. Circulation. 1999;99:237–242
  10. Ridker P, Buring J, Cook N, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391–397
  11. Rifai N, Buring JE, Lee I-M, et al. Is C-reactive protein specific for vascular disease in women?. Ann Intern Med. 2002;136:529–533
  12. Ridker P, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565
  13. Ridker P, Cushman M, Stampfer M, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425–428
  14. Majewski W, Zielinski A, Laciak M, et al. C-reactive protein and alpha-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs. Eur J Vasc Surg. 1993;7:628–632
  15. Rossi E, Biasucci L, Citterio F, et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation. 2002;105:800–803
  16. Yasojima K, Schwab C, McGeer E, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158:1039–1051
  17. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  18. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194–1197
  19. Kobayashi S, Inoue N, Ohashi Y, et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol. 2003;23:1398–1404
  20. Torzewski M, Rist C, Mortensen R, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000;20:2094–2099
  21. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997;43:52–58
  22. Danesh J, Pepys MB. C-reactive protein in healthy and in sick populations. Eur Heart J. 2000;21:1564–1565
  23. Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem. 2003;49:666–669
  24. Garcia-Moll X, Zouridakis E, Cole D, et al. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J. 2000;21:1598–1606
  25. Koh KK, Ahn JY, Kim DS, et al. Effect of hormone replacement therapy on tissue factor activity, C-reactive protein, and the tissue factor pathway inhibitor. Am J Cardiol. 2003;91:371–373
  26. Chandalia M, Cabo-Chan AJ, Devaraj S, et al. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003;88:3773–3776
  27. Anand S, Razak F, Yi Q, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol. 2004;24:1509–1515
  28. Pepys M. Amyloid, familial Mediterranean fever, and acute phase response. In:  Warrell DA,  Warrell DA editor. Oxford textbook of medicine. 4th ed. New York: Oxford University Press; 2003;p. 150–156
  29. Pepys M, Hirschfield G. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–1812
  30. Cassar K, Ford I, Greaves M, et al. Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty. Br J Surg. 2005;92:159–165
  31. Fiotti N, Giansante C, Ponte E, et al. Atherosclerosis and inflammation (Patterns of cytokine regulation in patients with peripheral arterial disease). Atherosclerosis. 1999;145:51–60
  32. Cruickshank AM, Fraser WD, Burns HJ, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci. 1990;79:161–165(Lond)
  33. Bolke E, Jehle PM, Storck M, et al. Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on acute phase response and clinical outcome. Clin Chim Acta. 2001;314:203–207
  34. Matzke S, Biancari F, Ihlberg L, et al. Increased preoperative C-reactive protein level as a prognostic factor for postoperative amputation after femoropopliteal bypass surgery for CLI. Ann Chir Gynaecol. 2001;90:19–22
  35. Schillinger M, Exner M, Mlekusch W, et al. Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology. 2003;227:419–425
  36. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199–204
  37. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005;76:2106–2115
  38. Mattila KJ, Pussinen PJ, Paju S. Dental infections and cardiovascular diseases: a review. J Periodontol. 2005;76:2085–2088
  39. Hujoel PP, Cunha-Cruz J, Loesche WJ, et al. Personal oral hygiene and chronic periodontitis: a systematic review. Periodontol 2000. 2005;37:29–34
  40. Ramseier CA. Potential impact of subject-based risk factor control on periodontitis. J Clin Periodontol. 2005;32:283–290

 This article resulted from preparation for research supported by a grant from The Society for Vascular Nursing.

PII: S1062-0303(07)00047-7

doi: 10.1016/j.jvn.2007.06.003

Journal of Vascular Nursing
Volume 25, Issue 3 , Pages 51-54 , September 2007

Article Tools